QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA
Clinical trial NCT01147965 · COMPLETED
Trial details
- NCT number
- NCT01147965
- Sponsor
- NantCell, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-16
- Primary completion
- 2017-05-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.